Published in J Mol Biol on September 25, 1976
RNA virus genomes hybridize to cellular rRNAs and to each other. J Virol (1986) 1.51
Poliovirus genome RNA hybridizes specifically to higher eukaryotic rRNAs. Nucleic Acids Res (1985) 1.33
Streptomycin-resistant Escherichia coli mutant temperature sensitive for the production of Qbeta-infective particles. J Virol (1977) 0.77
Ribonucleic acid bacteriophage release: requirement for host-controlled protein synthesis. J Virol (1971) 1.13
Heparin and the atherosclerotic process. Pharmacol Rev (1984) 0.90
Discriminative effect of rifampin of RNA replication of various RNA bacteriophages. J Virol (1975) 0.89
Inhibition of ribonucleic acid bacteriophage release from its host by rifampin. J Virol (1971) 0.87
Inhibition of RNA bacteriophage replication by rifampicin. J Mol Biol (1972) 0.84
Studies with the Chandler rotating loop. Evidence that thrombin generation is responsible for the formation of the artificial in vitro thrombi. Thromb Diath Haemorrh (1969) 0.83
Escherichia coli mutant temperature sensitive for group I RNA bacteriophages. J Virol (1978) 0.82
Mechanisms involved in the reduction of serum triglycerides in man upon adding unsaturated fats to the normal diet. Metabolism (1966) 0.80
The preparation and characterization of ribonucleic acid obtained by direct phenol extraction of intact cells of Escherichia coli from low ionic environment. Biochem Biophys Res Commun (1966) 0.80
Probable physiologic functions of heparin. Fed Proc (1977) 0.80
The conformation of ribonucleic acids in Escherichia coli ribosomes. Inferences from the mode of action of ribonuclease II. Biochem J (1967) 0.80
Heparin and atherosclerosis. A review of old and recent findings. Am Heart J (1980) 0.78
Inhibition of UDP-glucuronosyltransferases in rat liver microsomes by natural mutagens and carcinogens. Arch Toxicol (2001) 0.78
Serum lipemia: an overlooked cause of tissue hypoxia. Cardiology (1983) 0.76
The flowing clotting time (thrombus formation time) a sensitive test of hypercoagulability. Thromb Diath Haemorrh (1969) 0.75
Studies on the fate of parental bacteriophage RNA in the host. J Mol Biol (1970) 0.75
Heparin: physiology and pathobiology. Pathobiol Annu (1978) 0.75
Heparin, heparin fractions, and the atherosclerotic process. Semin Thromb Hemost (1985) 0.75
Postabsorptive serum triglyceride levels in man after the addition of highly unsaturated fish oils to the diet. Metabolism (1966) 0.75
Heparin and atherosclerosis. Monogr Atheroscler (1978) 0.75
Lipid disorders and heart-disease. Lancet (1970) 0.75
Heparin and vascular endothelium. Vasc Surg (1978) 0.75
The effect of cigarette smoking on various clotting time tests. Vasc Dis (1968) 0.75
Ultra-low-dose intravenous heparin. Lancet (1980) 0.75
The clinical use of heparin. Curr Ther Res Clin Exp (1975) 0.75
Cigarette smoking and thrombotic coagulation of human blood. Further in vitro studies. Arch Environ Health (1967) 0.75
Studies of optimal conditions for the measurement of circulating endogenous lipoprotein lipase activity. J Atheroscler Res (1970) 0.75
Heparin and atherosclerosis. Adv Lipid Res (1983) 0.75
The effect of a heparin antagonist on fasting serum triglycerides in man. J Atheroscler Res (1966) 0.75